Cloxacillinum [INN-Latin] en es it fr

Cloxacillinum [INN-Latin] Brand names, Cloxacillinum [INN-Latin] Analogs

Cloxacillinum [INN-Latin] Brand Names Mixture

  • No information avaliable

Cloxacillinum [INN-Latin] Chemical_Formula


Cloxacillinum [INN-Latin] RX_link

No information avaliable

Cloxacillinum [INN-Latin] fda sheet

Cloxacillinum [INN-Latin] msds (material safety sheet)

Cloxacillinum_[INN-Latin] MSDS

Cloxacillinum [INN-Latin] Synthesis Reference

No information avaliable

Cloxacillinum [INN-Latin] Molecular Weight

435.882 g/mol

Cloxacillinum [INN-Latin] Melting Point

No information avaliable

Cloxacillinum [INN-Latin] H2O Solubility

13.9 mg/L

Cloxacillinum [INN-Latin] State


Cloxacillinum [INN-Latin] LogP


Cloxacillinum [INN-Latin] Dosage Forms

Capsules (250 mg, 500 mg); Powder (125 mg/5 mL when reconstituted)

Cloxacillinum [INN-Latin] Indication

Used to treat infections caused by penicillinase-producing staphylococci, including pneumococci, group A beta-hemolytic streptococci, and penicillin G-sensitive and penicillin G-resistant staphylococci.

Cloxacillinum [INN-Latin] Pharmacology

Cloxacillin is a semisynthetic antibiotic in the same class as penicillin. Cloxacillin is for use against staphylococci that produce beta-lactamase.

Cloxacillinum [INN-Latin] Absorption

Well absorbed from the gastrointestinal tract.

Cloxacillinum [INN-Latin] side effects and Toxicity

Oral LD50 in rat and mouse is 5000 mg/kg. Intravenous LD50 in rat is 1660 mg/kg. Symptoms of overdose include wheezing, tightness in the chest, fever, itching, bad cough, blue skin color, fits, and swelling of face, lips, tongue, or throat.

Cloxacillinum [INN-Latin] Patient Information

Cloxacillinum [INN-Latin] Organisms Affected

Enteric bacteria and other eubacteria